Anzeige
Mehr »
Login
Dienstag, 04.03.2025 Börsentäglich über 12.000 News von 689 internationalen Medien
Mit Vollgas Richtung Expansion - Gelingt nun der Durchbruch?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JLYP | ISIN: KYG211081248 | Ticker-Symbol: 2M7C
Tradegate
03.03.25
17:01 Uhr
0,995 Euro
+0,030
+3,11 %
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD Chart 1 Jahr
5-Tage-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,9301,01009:41
0,9500,99009:42

Aktuelle News zur CHINA MEDICAL SYSTEM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14.02.China Medical System Holdings Ltd. (867.HK) is Included in the S&P Global Sustainability Yearbook 20255
24.01.China Medical System Holdings Ltd. (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10140SHENZHEN, CHINA, Jan. 24, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 24 January...
► Artikel lesen
24.01.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT SIGNING A COLLABORATION AGREEMENT FOR CLASS 1 INNOVATIVE DRUG MG-K10 HUMANIZED MONOCLONAL ANTIBODY ...1
08.01.China Medical System Holdings Ltd. (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type82SHENZHEN, CHINA, Jan. 08, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 8 January...
► Artikel lesen
CHINA MEDICAL SYSTEM Aktie jetzt für 0€ handeln
08.01.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT SIGNING A LICENSE, COLLABORATION AND DISTRIBUTION AGREEMENT OF IMPROVED NEW DRUG ZUNVEYL FOR THE ...-
09.12.24China Medical System Holdings Ltd.: First Prescriptions for Innovative Drug Lumeblue Issued in China156SHENZHEN, CHINA, Dec. 08, 2024 (GLOBE NEWSWIRE) -- On 6 December, China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that the first prescriptions for the innovative...
► Artikel lesen
02.12.24China Medical System Holdings Ltd. Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia166SHENZHEN, CHINA, Dec. 02, 2024 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 2 December...
► Artikel lesen
02.12.24CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT GAINING EXCLUSIVE COMMERCIALIZATION RIGHT OF CLASS 1 INNOVATIVE DRUG FOR THE TREATMENT OF GOUT ...1
27.11.24CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT APPROVAL OF DRUG CLINICAL TRIALS FOR INNOVATIVE DRUG DUAL AGONIST OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR/GLUCAGON ...-
05.11.24CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT NEW DRUG APPLICATION OF RUXOLITINIB PHOSPHATE CREAM FOR VITILIGO APPROVED IN HONG KONG-
18.10.24China Medical System Holdings Ltd.: First Ruxolitinib Cream's Prescriptions for Vitiligo Issued in the Greater Bay Area42SHENZHEN, CHINA, Oct. 18, 2024 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the "Group" or "CMS") is pleased to announce that on 18 October, the first batch of prescriptions of ruxolitinib...
► Artikel lesen
24.09.24China Medical System Holdings Ltd.: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China383SHENZHEN, CHINA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on September...
► Artikel lesen
24.09.24CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT NEW DRUG APPLICATION FOR VITILIGO INDICATION OF RUXOLITINIB PHOSPHATE CREAM ACCEPTED IN CHINA1
29.08.24Dividendenbekanntmachungen (29.08.2024)11.035 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ABC-MART INC  JP3152740001  33 JPY  0,2055 EUR  ADASTRIA CO LTD  JP3856000009  35 JPY  0,218 EUR  AEON CO LTD  JP3388200002  20 JPY  0...
► Artikel lesen
16.08.24China Medical System Holdings Ltd. (00867) Released its 2024 Interim Results: Steady Increase in Revenue and Profit Compared with 2H 2023226SHENZHEN, CHINA, Aug. 15, 2024 (GLOBE NEWSWIRE) -- On August 15, 2024, China Medical System Holdings Limited ("CMS" or the "Company") released its 2024 interim results announcement, with a steady...
► Artikel lesen
05.08.24China Medical System Holdings Ltd.: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in China175SHENZHEN, CHINA, Aug. 05, 2024 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 30 July...
► Artikel lesen
25.06.24China Medical System Holdings Ltd. Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China175SHENZHEN, CHINA, June 25, 2024 (GLOBE NEWSWIRE) -- On June 25, China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") announced the completion...
► Artikel lesen
18.06.24China Medical System Holdings Ltd.: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China297SHENZHEN, CHINA, June 18, 2024 (GLOBE NEWSWIRE) -- Innovative drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets (Lumeblue®) is an oral diagnostic drug, approved by China's NMPA...
► Artikel lesen
13.05.24Dividendenbekanntmachungen (13.05.2024)7.998 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ADECOAGRO SA  LU0584671464  0,1682 USD  0,1561 EUR  ADVANSIX INC  US00773T1016  0,16 USD  0,1485 EUR  AMERICAN WATER WORKS COMPANY INC  US0304201033  0...
► Artikel lesen
23.04.24China Medical System Holdings Ltd.: New Drug Application of Desidustat Tablets Accepted in China202SHENZHEN, CHINA, April 23, 2024 (GLOBE NEWSWIRE) -- Desidustat Tablets are novel, oral HIF-PHI for treating anaemia in non-dialysis adult chronic kidney disease patients. The Product is administrated...
► Artikel lesen
Seite:  Weiter >>
22 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1